Androgen receptor positive (AR+) breast cancer is a subtype of breast cancer that expresses androgen receptors. These receptors are proteins that bind to androgens, which are male hormones such as testosterone. Although breast cancer is more commonly associated with estrogen and progesterone receptors, AR+ breast cancer is gaining attention for its unique biological characteristics and potential therapeutic targets.
